Suvoda Executive and Leadership Team

Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the overarching corporate strategy and long-term vision for the organization. By prioritizing the development of innovative Interactive Response Technology, the Chief Executive Officer ensures that clinical trials maintain high standards of patient safety and operational precision. Wanninayake oversees the alignment of global teams to support complex study designs for biopharmaceutical clients. This leadership role involves constant evaluation of market trends to maintain a competitive edge in the health software sector. Through rigorous oversight of organizational goals, Jagath Wanninayake drives the company toward sustainable growth and technological excellence. The Chief Executive Officer maintains close collaboration with the Board to secure the resources necessary for scaling operations across international markets. Ultimately, Wanninayake fosters a culture of innovation that empowers clinical research organizations to overcome intricate supply chain hurdles with confidence and speed.

Brian Greenfield, the Chief Financial Officer at Suvoda, manages the fiscal health and long-term financial planning for the organization. Overseeing capital allocation and financial reporting, the Chief Financial Officer ensures that the company maintains the resources required to support ongoing software development and global expansion. Greenfield directs the financial strategy to optimize operational efficiency while supporting the delivery of Interactive Response Technology to diverse clinical research clients. This leadership role involves working closely with the executive team to evaluate investment opportunities and manage risk in a rapidly evolving health software landscape. By maintaining rigorous financial controls, Brian Greenfield supports the company's ability to scale its services for biopharmaceutical firms of all sizes. The Chief Financial Officer provides the analytical foundation necessary for strategic decision-making across the enterprise. Ultimately, Greenfield secures the financial stability required to sustain the company's mission of transforming clinical trials through advanced technology.

Jp Samar, the Chief Financial Officer & Founder at Suvoda, provides foundational financial oversight and strategic guidance for the company's growth. Overseeing the long-term financial architecture, the Chief Financial Officer & Founder ensures that the organization remains well-positioned to innovate within the clinical trial software market. Samar directs the development of financial models that support the scaling of Interactive Response Technology for global research partners. This leadership role involves maintaining the integrity of the company's fiscal strategy while fostering the entrepreneurial spirit that drives the business. By leveraging deep industry knowledge, Jp Samar supports the executive team in navigating complex market challenges and identifying new opportunities for expansion. The Chief Financial Officer & Founder collaborates with stakeholders to ensure that financial resources align with the company's mission of improving patient outcomes. Ultimately, Samar secures the financial health necessary to sustain the company's commitment to technological excellence.

John Samar, the Chief Financial Officer & Founder at Suvoda, manages the capital structure and financial governance that underpin the company's clinical trial solutions. Overseeing the fiscal planning for product development, the Chief Financial Officer & Founder ensures that the organization maintains the resources to support innovative study designs. Samar directs the financial analysis of market opportunities, enabling the company to effectively deploy its Interactive Response Technology across global research environments. This leadership role involves working with the executive team to ensure that financial performance supports the company's mission of transforming clinical trials. By maintaining a focus on sustainable growth, John Samar drives the company's ability to serve biopharmaceutical clients of all sizes. The Chief Financial Officer & Founder provides the strategic oversight necessary to navigate the complexities of the health software industry. Ultimately, Samar secures the financial stability required to continue the company's legacy of technological innovation.

Robert Hummel, the Chief Operating Officer at Suvoda, directs the internal operations and service delivery models that support the company's clinical trial software. Overseeing the implementation of Interactive Response Technology, the Chief Operating Officer ensures that customer and advisory services meet the rigorous demands of biopharmaceutical companies. Hummel manages the operational infrastructure required to support complex study designs and global trial requirements. This leadership role involves optimizing service delivery processes to enhance client satisfaction and operational efficiency. By coordinating with technical and support teams, Robert Hummel drives the successful deployment of software solutions across diverse geographic regions. The Chief Operating Officer monitors performance metrics to ensure that the company maintains high standards of quality and reliability. Ultimately, Hummel secures the operational foundation necessary for the company to deliver exceptional value to clinical research organizations and their patients.

Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, directs all regional operations and business development initiatives within the Japanese market. Overseeing the local implementation of Interactive Response Technology, the President, Suvoda (Japan) ensures that the company's solutions meet the specific regulatory and operational needs of regional biopharmaceutical clients. Fukasaku manages the local team to provide exceptional customer and advisory services, supporting complex clinical trials across the region. This leadership role involves adapting global strategies to the unique requirements of the local market while maintaining alignment with the company's overarching mission. By fostering strong relationships with local research organizations, Yuko Fukasaku drives the adoption of the company's software in a critical market. The President, Suvoda (Japan) monitors regional performance to ensure that the company achieves its growth objectives. Ultimately, Fukasaku secures a strong competitive position by delivering tailored support and innovative technology to clinical trial professionals.

Elena Filimonova, the Chief Marketing Officer at Suvoda, architects the global brand strategy and market positioning for the company's clinical trial software solutions. Overseeing all demand generation and communications, the Chief Marketing Officer ensures that the value proposition of the Interactive Response Technology reaches biopharmaceutical companies and research organizations worldwide. Filimonova drives initiatives that highlight the technical capabilities of the platform, specifically focusing on how configurable features solve complex randomization challenges. This leadership role involves managing cross-functional campaigns that elevate the company profile in competitive health technology markets. By analyzing market data and customer feedback, Elena Filimonova refines messaging to better serve the needs of clinical trial professionals. The Chief Marketing Officer collaborates with sales leadership to align marketing efforts with revenue targets. Ultimately, Filimonova secures a strong market presence by articulating the impact of the software on patient outcomes and trial success.

Kelly Snow, the Chief of Staff at Suvoda, coordinates strategic initiatives and facilitates communication across the executive leadership team. Overseeing the execution of high-priority projects, the Chief of Staff ensures that organizational goals remain aligned with the company's mission to improve clinical trial outcomes. Snow manages the flow of information between departments, enabling the leadership team to make informed decisions regarding the deployment of Interactive Response Technology. This leadership role involves streamlining internal processes to enhance productivity and cross-functional collaboration. By acting as a central point of contact for key stakeholders, Kelly Snow drives operational consistency and supports the implementation of corporate policies. The Chief of Staff monitors progress on critical milestones to ensure that the company meets the needs of its global biopharmaceutical clients. Ultimately, Snow optimizes the effectiveness of the executive office by managing complex workflows and fostering a cohesive organizational environment.

Andrew Prangle, the Account Executive & Chief Revenue Officer, Partnerships at Suvoda, drives revenue growth through the cultivation of strategic alliances and client relationships. Overseeing the partnership ecosystem, the Account Executive & Chief Revenue Officer, Partnerships ensures that the company's Interactive Response Technology reaches a broad network of biopharmaceutical firms and clinical research organizations. Prangle manages the sales strategy for key accounts, focusing on how the software solves complex supply chain and randomization challenges. This leadership role involves negotiating high-value agreements and expanding the company's footprint in international markets. By aligning partnership goals with revenue targets, Andrew Prangle supports the company's overall growth trajectory. The Account Executive & Chief Revenue Officer, Partnerships collaborates with marketing and product teams to ensure that partnership offerings remain competitive and relevant. Ultimately, Prangle secures long-term revenue streams by building trust and delivering measurable value to clinical trial partners.